TNF A liquid formulation of anti-TNF alpha antibody
The present invention relates to a liquid formulation of an anti-TNF alpha antibody, and specifically, to a liquid formulation of adalimumab. The anti-TNF alpha antibody, specifically a liquid formulation of adalimumab of the present invention reduces the generation of byproducts of adalimumab durin...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention relates to a liquid formulation of an anti-TNF alpha antibody, and specifically, to a liquid formulation of adalimumab. The anti-TNF alpha antibody, specifically a liquid formulation of adalimumab of the present invention reduces the generation of byproducts of adalimumab during the storage period, thereby enabling long term storage. The liquid formulation of an anti-TNF alpha antibody contains the anti-TNF alpha antibody, a stabilizer, a surfactant, and arginine.
본 발명은 항-TNF 알파 항체, 구체적으로 아달리무맙의 액상 제제에 관한 것이다. |
|---|